BrucellaCAPT® (screening/titration) | BRUCAPT | Vircell

BRUCELLACAPT®

Immunocapture-agglutination test for the detection of total antibodies against Brucella .

• Ideal serological technique for the diagnosis of chronic brucellosis and treatment monitoring
• Visual reading in 24 hours. Does not require washing or predilution of samples
• Maximum sensitivity and specificity
• Product of great international recognition collected in scientific literature
• Allows performing titration and screening protocols

Brucella melitensis infection continues to be recognized as a major public health challenge that poses a great economic and financial burden in those countries where this disease is endemic. The intracellular location of this bacterium keeps it protected from antibiotics and bactericidal factors in plasma, which can lead to the chronic nature of the infection .

BRUCELLACAPT® allows to carry out, in a simple and comfortable way, the detection of antibodies typical of the advanced phases of the disease , being specially designed for the diagnosis of chronic brucellosis.

The scientific literature demonstrates that a rapid reduction in BRUCELLECAPT® titers, together with a decrease in symptoms, is a good indicator of patient recovery .